Search by Drug Name or NDC
NDC 00173-0873-10 Incruse Ellipta 62.5 ug/1 Details
Incruse Ellipta 62.5 ug/1
Incruse Ellipta is a ORAL AEROSOL, POWDER in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GlaxoSmithKline LLC. The primary component is UMECLIDINIUM BROMIDE.
MedlinePlus Drug Summary
Umeclidinium oral inhalation is used in adults to control wheezing, shortness of breath, coughing, and chest tightness caused by chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways, that includes chronic bronchitis and emphysema). Umeclidinium inhalation is in a class of medications called anticholinergics. It works by relaxing and opening air passages in the lungs, making it easier to breathe.
Related Packages: 00173-0873-10Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Umeclidinium Oral Inhalation
Product Information
| NDC | 00173-0873 |
|---|---|
| Product ID | 0173-0873_e528d273-b49e-4095-be44-1ac2ff45252e |
| Associated GPIs | 44100090208030 |
| GCN Sequence Number | 072375 |
| GCN Sequence Number Description | umeclidinium bromide BLST W/DEV 62.5 MCG INHALATION |
| HIC3 | B61 |
| HIC3 Description | ANTICHOLINERGICS, ORALLY INHALED LONG ACTING |
| GCN | 36574 |
| HICL Sequence Number | 041115 |
| HICL Sequence Number Description | UMECLIDINIUM BROMIDE |
| Brand/Generic | Brand |
| Proprietary Name | Incruse Ellipta |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | umeclidinium |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | AEROSOL, POWDER |
| Route | ORAL |
| Active Ingredient Strength | 62.5 |
| Active Ingredient Units | ug/1 |
| Substance Name | UMECLIDINIUM BROMIDE |
| Labeler Name | GlaxoSmithKline LLC |
| Pharmaceutical Class | Anticholinergic [EPC], Cholinergic Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA205382 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00173-0873-10 (00173087310)
| NDC Package Code | 0173-0873-10 |
|---|---|
| Billing NDC | 00173087310 |
| Package | 1 TRAY in 1 CARTON (0173-0873-10) / 1 INHALER in 1 TRAY / 30 AEROSOL, POWDER in 1 INHALER |
| Marketing Start Date | 2014-04-30 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 11.3292 |
| Pricing Unit | EA |
| Effective Date | 2023-06-21 |
| NDC Description | INCRUSE ELLIPTA 62.5 MCG INH |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 2, 5 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis